# Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

> **NCT03963167** · — · COMPLETED · sponsor: **Chiesi Italia** · enrollment: 661 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** BDP/FF/G fixed combination

## Key facts

- **NCT ID:** NCT03963167
- **Lead sponsor:** Chiesi Italia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-21
- **Primary completion:** 2022-03-04
- **Final completion:** 2022-03-04
- **Target enrollment:** 661 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963167, "Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03963167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*